Evidence map›Paper›PMID 27386863›Full record

ReviewPLoS genetics2016

Telomere Length and the Cancer-Atherosclerosis Trade-Off.

Rivka C Stone, Kent Horvath, Jeremy D Kark, Ezra Susser, Sarah A Tishkoff, Abraham Aviv

Open access · goldAbstract readReview
In one paragraph

Review in PLoS genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
9.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it, 82 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. The bullwhip effect, T-cell telomeres, and SARS-CoV-2.The lancet. Healthy longevity · 2022
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Telomeres and COVID-19.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Genetic and epigenetic regulation of human aging and longevity.Biochimica et biophysica acta. Molecular basis of disease · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 2 countries.

Rivka C StoneThe Center of Human Development and Aging, New Jersey Medical School, Rutgers, Newark, New Jersey, United States of America.
Kent HorvathThe Center of Human Development and Aging, New Jersey Medical School, Rutgers, Newark, New Jersey, United States of America.
Jeremy D KarkEpidemiology Unit, Hebrew University-Hadassah School of Public Health and Community Medicine, Jerusalem, Israel.
Ezra SusserDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, United States of America.
Sarah A TishkoffDepartment of Genetics, School of Arts and Sciences, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Abraham AvivThe Center of Human Development and Aging, New Jersey Medical School, Rutgers, Newark, New Jersey, United States of America.
Rutgers, The State University of New Jersey · USColumbia University · USHebrew University of Jerusalem · ILRutgers New Jersey Medical SchoolUniversity of Pennsylvania · US

Funding

Determinants of Leukocyte Telomere Length at BirthR01HD071180 · NICHD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI AVIV, ABRAHAM, FACTOR-LITVAK, PAM R · 2012 to 2016
$3.3M
Leukocyte Telomere Length and Cardiovascular Disease in Jackson Heart StudyR01HL116446 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI AVIV, ABRAHAM, REINER, ALEXANDER P · 2013 to 2016
$3.1M
Integrative Genomics of Body Size and Metabolism in Ethnically Diverse AfricansR01GM113657 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI TISHKOFF, SARAH ANNE · 2015 to 2019
$2.8M
Integrative nutrigenomic and metabolomic analyses of Africans with variable dietsR01DK104339 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI TISHKOFF, SARAH ANNE · 2015 to 2018
$1.4M
NHLBI NIH HHS R01 HL116446NICHD NIH HHS R01 HD071180NIDDK NIH HHS R01 DK104339NIGMS NIH HHS R01 GM113657
6 · The paper itself

Abstract

Modern humans, the longest-living terrestrial mammals, display short telomeres and repressed telomerase activity in somatic tissues compared with most short-living small mammals. The dual trait of short telomeres and repressed telomerase might render humans relatively resistant to cancer compared with short-living small mammals. However, the trade-off for cancer resistance is ostensibly increased age-related degenerative diseases, principally in the form of atherosclerosis. In this communication, we discuss (a) the genetics of human telomere length, a highly heritable complex trait that is influenced by genetic ancestry, sex, and paternal age at conception, (b) how cancer might have played a role in the evolution of telomere biology across mammals, (c) evidence that in modern humans telomere length is a determinant (rather than only a biomarker) of cancer and atherosclerosis, and (d) the potential influence of relatively recent evolutionary forces in fashioning the variation in telomere length across and within populations, and their likely lasting impact on major diseases in humans. Finally, we propose venues for future research on human telomere genetics in the context of its potential role in shaping the modern human lifespan.

Indexed as

AgingAtherosclerosisHumansLongevityNeoplasmsTelomereTelomere HomeostasisTelomere Shortening

Identifiers

PMID27386863
PMCPMC4936693
OpenAlexW2472561123

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.